InvestorsHub Logo
Followers 7
Posts 2799
Boards Moderated 0
Alias Born 01/17/2010

Re: None

Wednesday, 10/13/2010 8:55:48 AM

Wednesday, October 13, 2010 8:55:48 AM

Post# of 105534
Thank goodness my little old CBAI.OB has nothing to do with the embryonic lab experiment. Looks like the boys want a few more to fall off before we launch. Nice tactics... Pssst! One observation and I move on....ok? Most get hung up on just two words 'stem cells'. You don't need to try so hard. Pullback, reset and approach from a new angle. smile You guys are the best!

Dew, I predict grant announcement if and when dignitaries do arrive at CBAI.OB HQ. I think .05 is a safe est. if all goes well in Nevada. I hope for more but I do have a decent range .03, .05, $1, $100, $300 idk. It depends on the O/S. If addressed by BCBS ownership by 39 Independents, buyback... $15 - $30 might be the correct range. Too many factors that can change everything from mirage to real on a moments notice.

I have been passing the days and weeks with you guys waiting for this to be fully cooked and brought to the dinner table for a Big feast. I smell it. I see it. We need to say grace and prepare to feast on the meal. We each have different appetites, different pallet's, various wants and desires from the prepared meal. Be gracious at the dinner table. That's why it is a black tie invite. Welcome to the complex world of living and dreaming. Regardless be a respectful guest and consume what you can but most importantly be happy. Perhaps early but I will say welcome CBAI and BCBS. Come join us.

Rallytear, I have thick skin and I like dining with my enemy so you are invited too. I keep folks like you close. Who knows what mischief you can cause out in about without eyes on you. Bring Pitt's and CBAI W with you too. Just RSVP thanks!

Checkout the organ donation changes on the horizon:

HRSA OPTN/UNOS Board Approves Resource to Assess Quality of Deceased Donor Kidneys, Additional Disclosure for Living Donors

Richmond, Va. -- As transplant professionals consider offers of kidneys from deceased donors, a key issue is a medical assessment of the organ's likelihood to function in the long term. The OPTN/UNOS Board of Directors, at its meeting June 21 and 22, unanimously approved the use of an informational reference using a statistical measure to assess kidney donor quality. The measure is called the Kidney Donor Profile Index (KDPI).

"We encourage organ donation and transplant professionals to become familiar with KDPI," said James Wynn, M.D., president of the OPTN and UNOS and chair of the OPTN/UNOS Board of Directors. "At this point this is purely an informational tool for transplant clinicians and donation professionals to help them assess, among other factors, whether a given donor offer is suitable for a given potential recipient. However, many people support the concept of using KDPI in future kidney allocation policy, and we hope as people use it as a reference they will be better able to assess its potential as a component of policy." The KDPI is calculated individually for each potential donor, incorporating a variety of medical factors known to have a statistical influence on long-term graft survival (function of the transplanted organ). Some of these factors include the donor's age, weight, mechanism of death and history of certain medical conditions.

The score will be expressed in a percentile value between zero, for an organ with the longest expected survival potential, and one, for an organ with the shortest expected survival potential. The score is expected to provide a much more accurate assessment of long-term potential function of donor kidneys when compared to the current classification of donors as either "standard" or "extended criteria."

In other action, the Board approved a new provision in the OPTN bylaws requiring living donor kidney and liver transplant programs to document disclosure to each potential donor that the sale or purchase of human organs is a Federal crime. This bylaw is intended to promote greater consistency and vigilance in the efforts of living donor programs to educate and screen donors. While not addressed at this time, a similar disclosure to potential recipients of living donor organs may be considered in the future.

As soon as it is available, an executive summary of all Board meeting actions will be posted to the OPTN Web site. The site also contains summaries of proceedings from past OPTN/UNOS Board meetings.

The Organ Procurement and Transplantation Network (OPTN) is operated under contract with the U.S. Department of Health and Human Services, Health Resources and Services Administration, Division of Transplantation by the United Network for Organ Sharing (UNOS). The OPTN brings together medical professionals, transplant recipients and donor families to develop organ transplantation policy.
http://optn.transplant.hrsa.gov/news/newsDetail.asp?id=1375
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.